Search

Your search keyword '"Pillay, Deenan"' showing total 993 results

Search Constraints

Start Over You searched for: Author "Pillay, Deenan" Remove constraint Author: "Pillay, Deenan" Language english Remove constraint Language: english
993 results on '"Pillay, Deenan"'

Search Results

2. Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa

3. Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study

4. The met and unmet health needs for HIV, hypertension, and diabetes in rural KwaZulu-Natal, South Africa: analysis of a cross-sectional multimorbidity survey

5. Lateral flow test engineering and lessons learned from COVID-19

6. Recommendations on data sharing in HIV drug resistance research

8. Isisekelo Sempilo study protocol for the effectiveness of HIV prevention embedded in sexual health with or without peer navigator support (Thetha Nami) to reduce prevalence of transmissible HIV amongst adolescents and young adults in rural KwaZulu-Natal: a 2 × 2 factorial randomised controlled trial

10. Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results.

11. Association of pregnancy with engagement in HIV care among women with HIV in the UK: a cohort study

12. Rapid roll out of SARS-CoV-2 antibody testing—a concern

13. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

14. Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study

15. Deep learning of HIV field-based rapid tests

16. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

17. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial

20. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda

21. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines

22. Digital technologies in the public-health response to COVID-19

23. Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis

24. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

25. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

26. HIV transmission dynamics and populationwide drug resistance in rural South Africa.

29. Ethical considerations in global HIV phylogenetic research

30. A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study

31. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

32. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

33. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

35. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa

36. Taking connected mobile-health diagnostics of infectious diseases to the field

42. Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

43. Reply to Cohen et al

44. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

46. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study

50. HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study.

Catalog

Books, media, physical & digital resources